Geneoscopy to Present Research on Inflammatory Bowel Disease at Crohn’s & Colitis Foundation’s IBD Innovate 2024 Conference
Data shows noninvasive stool RNA technology may help providers assess therapeutic response and monitor disease activity for patients with…
Geneoscopy Forms Scientific Advisory Board to Support Advancement of Precision Immunology Diagnostics for Inflammatory Bowel Disease (IBD)
ST. LOUIS, MO – January 17, 2024 – Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…
Geneoscopy Files Inter Partes Review Petition Challenging Exact Sciences’ Patent
Extensive prior art renders Exact Sciences’ patent relating to stool collection and processing invalid ST. LOUIS, Mo. – (BUSINESS WIRE)…
Geneoscopy and Adiso Therapeutics Announce Strategic Collaboration to Investigate New Therapeutic Options for Patients with Inflammatory Bowel Disease
Adiso to Utilize Noninvasive RNA Technology Developed by Geneoscopy as a Precision Immunology…
Geneoscopy Signs Multi-Year Agreement with Labcorp to Distribute Noninvasive Multi-Target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test
Collaboration expected to increase provider and patient access to potentially life-saving colorectal cancer screening that enables earlier disease…
Don Hardison Appointed Chairman of the Board at Geneoscopy
ST. LOUIS. MO – November 9, 2023 – Geneoscopy, a life sciences company focused on developing diagnostic tests for gastrointestinal health, has…
JAMA Publishes Geneoscopy’s Pivotal CRC-PREVENT Trial Results, Reporting Highest Sensitivity for Detecting Colorectal Cancer and Advanced Adenomas Among Available Noninvasive Screening Tests
Geneoscopy’s noninvasive, multi-target, stool RNA (mt-sRNA) colorectal cancer screening test showed extraordinary sensitivity for detecting…
Geneoscopy to Present and Exhibit at American College of Gastroenterology 2023 Annual Meeting
Company to Showcase Its Noninvasive RNA-based Technology Platform Designed to Improve Diagnostic Tools for Gastrointestinal Health ST LOUIS, MO –…
Geneoscopy CEO Andrew Barnell to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
“…We believe that our pipeline of tests will enable a precision medicine approach to GI disease management and treatment, bringing value…